Panagiotis Baliakas

Prognostic impact of epigenetic classification in chronic lymphocytic leukemia: The case of subset #2

Bhoi, Sujata; Ljungström, Viktor; Baliakas, Panagiotis; Mattsson, Mattias et al.

Ingår i Epigenetics, s. 449-455, 2016

• DOI för Prognostic impact of epigenetic classification in chronic lymphocytic leukemia: The case of subset #2

The histone methyltransferase EZH2 as a novel prosurvival factor in clinically aggressive chronic lymphocytic leukemia

Papakonstantinou, Nikos; Ntoufa, Stavroula; Chartomatsidou, Elisavet; Kotta, Konstantia et al.

Ingår i Oncotarget, s. 35946-35959, 2016

• DOI för The histone methyltransferase EZH2 as a novel prosurvival factor in clinically aggressive chronic lymphocytic leukemia

Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors

Sutton, Lesley-Ann; Young, Emma; Baliakas, Panagiotis; Hadzidimitriou, Anastasia et al.

Ingår i Haematologica, s. 959-967, 2016

• DOI för Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors

UGT2B17 expression: a novel prognostic marker within IGHV-mutated chronic lymphocytic leukemia?

Bhoi, Sujata; Baliakas, Panagiotis; Cortese, Diego; Mattsson, Mattias et al.

Ingår i Haematologica, 2016

• DOI för UGT2B17 expression: a novel prognostic marker within IGHV-mutated chronic lymphocytic leukemia?

An Immunogenetic Signature of Ongoing Antigen Interactions in Splenic Marginal Zone Lymphoma Expressing IGHV1-2*04 Receptors

Bikos, Vasilis; Karypidou, Maria; Stalika, Evangelia; Baliakas, Panagiotis et al.

Ingår i Clinical Cancer Research, s. 2032-2040, 2016

• DOI för An Immunogenetic Signature of Ongoing Antigen Interactions in Splenic Marginal Zone Lymphoma Expressing IGHV1-2*04 Receptors

Prognostic indices in chronic lymphocytic leukaemia: where do we stand how do we proceed?

Baliakas, Panagiotis; Mattsson, Mattias; Stamatopoulos, Kostas; Rosenquist Brandell, Richard

Ingår i Journal of Internal Medicine, s. 347-357, 2016

• DOI för Prognostic indices in chronic lymphocytic leukaemia: where do we stand how do we proceed?

Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations

Ljungström, Viktor; Cortese, Diego; Young, Emma; Pandzic, Tatjana et al.

Ingår i Blood, s. 1007-1016, 2016

• DOI för Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations

Reappraising prognosis in chronic lymphocytic leukemia

Baliakas, Panagiotis

2016

• Ladda ner fulltext (pdf) av Reappraising prognosis in chronic lymphocytic leukemia

ARResT/AssignSubsets: a novel application for robust subclassification of chronic lymphocytic leukemia based on B cell receptor IG stereotypy

Bystry, Vojtech; Agathangelidis, Andreas; Bikos, Vasilis; Sutton, Lesley Ann et al.

Ingår i Bioinformatics, s. 3844-3846, 2015

• DOI för ARResT/AssignSubsets: a novel application for robust subclassification of chronic lymphocytic leukemia based on B cell receptor IG stereotypy

HIGHER-ORDER IMMUNOGLOBULIN SEQUENCE RELATIONS FOR MAJOR SUBSETS OF CHRONIC LYMPHOCYTIC LEUKEMIA: UNIQUENESS VERSUS EQUIVALENCE

Agathangelidis, A.; Bystry, V.; Hadzidimitriou, A.; Sutton, L. A. et al.

Ingår i Haematologica, s. 47-48, 2015

ADDITIONAL TRISOMIES AMONGST PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA CARRYING TRISOMY 12: THE PARTNER CHROMOSOME MAKES A DIFFERENCE

Baliakas, Panagiotis; Puiggros, A.; Xochelli, Aliki; Sutton, L. -A et al.

Ingår i Haematologica, s. 224-224, 2015

Personalized Modeling of Disease Evolution in CLL: Does Statistical Significance Translate into Predictive Accuracy?

Chatzilari, Elisavet; Baliakas, Panagiotis; Xochelli, Aliki; Maronidis, Anastasios et al.

Ingår i Blood, 2015

Prognostic relevance of MYD88 mutations in CLL: the jury is still out

Baliakas, Panagiotis; Hadzidimitriou, Anastasia; Agathangelidis, Andreas; Rossi, Davide et al.

Ingår i Blood, s. 1043-1044, 2015

• DOI för Prognostic relevance of MYD88 mutations in CLL: the jury is still out

Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations

Baliakas, Panagiotis; Agathangelidis, Andreas; Hadzidimitriou, Anastasia; Sutton, Lesley-Ann et al.

Ingår i Blood, s. 856-859, 2015

• DOI för Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations

Splenic marginal-zone lymphoma: ontogeny and genetics

Baliakas, Panagiotis; Strefford, Jonathan C.; Bikos, Vasilis; Parry, Marina et al.

Ingår i Leukemia and Lymphoma, s. 301-310, 2015

• DOI för Splenic marginal-zone lymphoma: ontogeny and genetics

Recurrent mutations refine prognosis in chronic lymphocytic leukemia

Baliakas, Panagiotis; Hadzidimitriou, A; Sutton, Lesley Ann; Rossi, D et al.

Ingår i Leukemia, s. 329-336, 2015

• DOI för Recurrent mutations refine prognosis in chronic lymphocytic leukemia

Superior Long-Term Repopulating Capacity of G-CSF+Plerixafor-Mobilized Blood: Implications for Stem Cell Gene Therapy by Studies in the Hbb(th-3) Mouse Model

Psatha, Nikoleta; Sgouramali, Eleni; Gkountis, Antonios; Siametis, Athanasios et al.

Ingår i Human Gene Therapy Methods, s. 317-327, 2014

• DOI för Superior Long-Term Repopulating Capacity of G-CSF+Plerixafor-Mobilized Blood: Implications for Stem Cell Gene Therapy by Studies in the Hbb(th-3) Mouse Model

Immunoglobulin Heavy Variable Genes and Alleles: New Entities, New Names and Implications for Research and Prognostication in CLL

Xochelli, A.; Agathangelidis, A.; Kavakiotis, I.; Minga, E. et al.

Ingår i Haematologica, s. 49-49, 2014

Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study

Baliakas, Panagiotis; Hadzidimitriou, Anastasia; Sutton, Lesley-Ann; Minga, Eva et al.

Ingår i LANCET HAEMATOLOGY, 2014

• DOI för Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study

Stereotyped B-cell receptors in chronic lymphocytic leukemia

Agathangelidis, Andreas; Vardi, Anna; Baliakas, Panagiotis; Stamatopoulos, Kostas

Ingår i Leukemia and Lymphoma, s. 2252-2261, 2014

• DOI för Stereotyped B-cell receptors in chronic lymphocytic leukemia

The frequency of TP53 gene defects differs between chronic lymphocytic leukaemia subgroups harbouring distinct antigen receptors

Malcikova, Jitka; Stalika, Evangelia; Davis, Zadie; Plevova, Karla et al.

Ingår i British Journal of Haematology, s. 621-625, 2014

• DOI för The frequency of TP53 gene defects differs between chronic lymphocytic leukaemia subgroups harbouring distinct antigen receptors

Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: A systematic reappraisal of classic cytogenetic data

Baliakas, Panagiotis; Iskas, Michalis; Gardiner, Anne; Davis, Zadie et al.

Ingår i American Journal of Hematology, s. 249-255, 2014

• DOI för Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: A systematic reappraisal of classic cytogenetic data

Clonal B-cell lymphocytosis exhibiting immunophenotypic features consistent with a marginal-zone origin: is this a distinct entity?

Xochelli, Aliki; Kalpadakis, Christina; Gardiner, Anne; Baliakas, Panagiotis et al.

Ingår i Blood, s. 1199-1206, 2014

• DOI för Clonal B-cell lymphocytosis exhibiting immunophenotypic features consistent with a marginal-zone origin: is this a distinct entity?

Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2

Strefford, J. C.; Sutton, Lesley Ann; Baliakas, Panagiotis; Agathangelidis, A. et al.

Ingår i Leukemia, s. 2196-2199, 2013

• DOI för Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2

Disease characteristics and outcomes of acute myeloid leukemia in germline RUNX1 deficiency (Familial Platelet Disorder with associated Myeloid Malignancy)

Ernst, Martijn P. T.; Versluis, Jurjen; Valk, Peter J. M.; Bierings, Marc et al.

Ingår i HemaSphere, 2025

• DOI för Disease characteristics and outcomes of acute myeloid leukemia in germline RUNX1 deficiency (Familial Platelet Disorder with associated Myeloid Malignancy)
• Ladda ner fulltext (pdf) av Disease characteristics and outcomes of acute myeloid leukemia in germline RUNX1 deficiency (Familial Platelet Disorder with associated Myeloid Malignancy)

Precision Diagnostics in Myeloid Malignancies: Development and Validation of a National Capture‐Based Gene Panel

Orsmark‐Pietras, Christina; Lyander, Anna; Ladenvall, Claes; Hallström, Björn et al.

Ingår i Genes, Chromosomes and Cancer, 2024

• DOI för Precision Diagnostics in Myeloid Malignancies: Development and Validation of a National Capture‐Based Gene Panel
• Ladda ner fulltext (pdf) av Precision Diagnostics in Myeloid Malignancies: Development and Validation of a National Capture‐Based Gene Panel

ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-2024 update

Malcikova, Jitka; Pavlova, Sarka; Baliakas, Panagiotis; Chatzikonstantinou, Thomas et al.

Ingår i Leukemia, s. 1455-1468, 2024

• DOI för ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-2024 update
• Ladda ner fulltext (pdf) av ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-2024 update

Cancer associated variant enrichment CAVE, a gene agnostic approach to identify low burden variants in chronic lymphocytic leukemia

Yaacov, Adar; Lazarian, Gregory; Pandzic, Tatjana; Weström, Simone et al.

Ingår i Scientific Reports, 2024

• DOI för Cancer associated variant enrichment CAVE, a gene agnostic approach to identify low burden variants in chronic lymphocytic leukemia
• Ladda ner fulltext (pdf) av Cancer associated variant enrichment CAVE, a gene agnostic approach to identify low burden variants in chronic lymphocytic leukemia

Integrating a Polygenic Risk Score into a clinical setting would impact risk predictions in familial breast cancer

Baliakas, Panagiotis; Munters, Arielle R; Kämpe, Anders; Tesi, Bianca et al.

Ingår i Journal of Medical Genetics, s. 150-154, 2024

• DOI för Integrating a Polygenic Risk Score into a clinical setting would impact risk predictions in familial breast cancer
• Ladda ner fulltext (pdf) av Integrating a Polygenic Risk Score into a clinical setting would impact risk predictions in familial breast cancer

Disease characteristics and outcomes of acute myeloid leukemia in germline RUNX1 deficiency (Familial Platelet Disorder with associated Myeloid Malignancy)

Ernst, Martijn P. T.; Versluis, Jurjen; Valk, Peter J. M.; Bierings, Marc et al.

Ingår i HemaSphere, 2025

• DOI för Disease characteristics and outcomes of acute myeloid leukemia in germline RUNX1 deficiency (Familial Platelet Disorder with associated Myeloid Malignancy)
• Ladda ner fulltext (pdf) av Disease characteristics and outcomes of acute myeloid leukemia in germline RUNX1 deficiency (Familial Platelet Disorder with associated Myeloid Malignancy)

Precision Diagnostics in Myeloid Malignancies: Development and Validation of a National Capture‐Based Gene Panel

Orsmark‐Pietras, Christina; Lyander, Anna; Ladenvall, Claes; Hallström, Björn et al.

Ingår i Genes, Chromosomes and Cancer, 2024

• DOI för Precision Diagnostics in Myeloid Malignancies: Development and Validation of a National Capture‐Based Gene Panel
• Ladda ner fulltext (pdf) av Precision Diagnostics in Myeloid Malignancies: Development and Validation of a National Capture‐Based Gene Panel

Cancer associated variant enrichment CAVE, a gene agnostic approach to identify low burden variants in chronic lymphocytic leukemia

Yaacov, Adar; Lazarian, Gregory; Pandzic, Tatjana; Weström, Simone et al.

Ingår i Scientific Reports, 2024

• DOI för Cancer associated variant enrichment CAVE, a gene agnostic approach to identify low burden variants in chronic lymphocytic leukemia
• Ladda ner fulltext (pdf) av Cancer associated variant enrichment CAVE, a gene agnostic approach to identify low burden variants in chronic lymphocytic leukemia

Integrating a Polygenic Risk Score into a clinical setting would impact risk predictions in familial breast cancer

Baliakas, Panagiotis; Munters, Arielle R; Kämpe, Anders; Tesi, Bianca et al.

Ingår i Journal of Medical Genetics, s. 150-154, 2024

• DOI för Integrating a Polygenic Risk Score into a clinical setting would impact risk predictions in familial breast cancer
• Ladda ner fulltext (pdf) av Integrating a Polygenic Risk Score into a clinical setting would impact risk predictions in familial breast cancer

Pathogenic DDX41 variants, possible response predictors to low-dose melphalan in hypo- and normocellular MDS and AML

Nyquist, Otto Emil; Dalgaard, Jakob; Spetalen, Signe; Torkildsen, Synne et al.

Ingår i British Journal of Haematology, s. 724-729, 2024

• DOI för Pathogenic DDX41 variants, possible response predictors to low-dose melphalan in hypo- and normocellular MDS and AML

How to manage patients with germline DDX41 variants: Recommendations from the Nordic working group on germline predisposition for myeloid neoplasms

Baliakas, Panagiotis; Tesi, Bianca; Cammenga, Jörg; Stray-Pedersen, Asbjørg et al.

Ingår i HemaSphere, 2024

• DOI för How to manage patients with germline DDX41 variants: Recommendations from the Nordic working group on germline predisposition for myeloid neoplasms
• Ladda ner fulltext (pdf) av How to manage patients with germline DDX41 variants: Recommendations from the Nordic working group on germline predisposition for myeloid neoplasms

Novel pathological variants of NHP2 affect N-terminal domain flexibility, protein stability, H/ACA Ribonucleoprotein (RNP) complex formation and telomerase activity

Maliński, Bartosz; Vertemara, Jacopo; Faustini, Elena; Ladenvall, Claes et al.

Ingår i Human Molecular Genetics, s. 2901-2912, 2023

• DOI för Novel pathological variants of NHP2 affect N-terminal domain flexibility, protein stability, H/ACA Ribonucleoprotein (RNP) complex formation and telomerase activity
• Ladda ner fulltext (pdf) av Novel pathological variants of NHP2 affect N-terminal domain flexibility, protein stability, H/ACA Ribonucleoprotein (RNP) complex formation and telomerase activity

T cell receptor gene repertoire profiles in subgroups of patients with chronic lymphocytic leukemia bearing distinct genomic aberrations

Vlachonikola, Elisavet; Pechlivanis, Nikolaos; Karakatsoulis, Georgios; Sofou, Electra et al.

Ingår i Frontiers in Oncology, 2023

• DOI för T cell receptor gene repertoire profiles in subgroups of patients with chronic lymphocytic leukemia bearing distinct genomic aberrations
• Ladda ner fulltext (pdf) av T cell receptor gene repertoire profiles in subgroups of patients with chronic lymphocytic leukemia bearing distinct genomic aberrations

The clinical phenotype of germline RUNX1 mutations in relation to the accompanying somatic variants and RUNX1 isoform expression

Cabrerizo Granados, David; Barbosa, Indira; Baliakas, Panagiotis; Hellström‐Lindberg, Eva et al.

Ingår i Genes, Chromosomes and Cancer, s. 672-677, 2023

• DOI för The clinical phenotype of germline RUNX1 mutations in relation to the accompanying somatic variants and RUNX1 isoform expression
• Ladda ner fulltext (pdf) av The clinical phenotype of germline RUNX1 mutations in relation to the accompanying somatic variants and RUNX1 isoform expression

Somatic Exonic Deletions in RUNX1 Constitutes a Novel Recurrent Genomic Abnormality in Acute Myeloid Leukemia

Eriksson, Anna; Engvall, Marie; Mathot, Lucy; Österroos, Albin et al.

Ingår i Clinical Cancer Research, s. 2826-2834, 2023

• DOI för Somatic Exonic Deletions in RUNX1 Constitutes a Novel Recurrent Genomic Abnormality in Acute Myeloid Leukemia

Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY

Mansouri, Larry; Thorvaldsdottir, Birna; Sutton, Lesley-Ann; Karakatsoulis, Georgios et al.

Ingår i Leukemia, s. 339-347, 2023

• DOI för Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY
• Ladda ner fulltext (pdf) av Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY

BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib

Bonfiglio, Silvia; Sutton, Lesley-Ann; Ljungström, Viktor; Capasso, Antonella et al.

Ingår i Blood Advances, s. 2794-2806, 2023

• DOI för BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib
• Ladda ner fulltext (pdf) av BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib

Early response evaluation by single cell signaling profiling in acute myeloid leukemia

Tislevoll, Benedicte Sjo; Hellesoy, Monica; Fagerholt, Oda Helen Eck; Gullaksen, Stein-Erik et al.

Ingår i Nature Communications, 2023

• DOI för Early response evaluation by single cell signaling profiling in acute myeloid leukemia
• Ladda ner fulltext (pdf) av Early response evaluation by single cell signaling profiling in acute myeloid leukemia

Loss of Y and clonal hematopoiesis in blood: two sides of the same coin?

Ljungström, Viktor; Mattisson, Jonas; Halvardson, Jonatan; Pandzic, Tatjana et al.

Ingår i Leukemia, s. 889-891, 2022

• DOI för Loss of Y and clonal hematopoiesis in blood: two sides of the same coin?
• Ladda ner fulltext (pdf) av Loss of Y and clonal hematopoiesis in blood: two sides of the same coin?

Cytogenetics in Chronic Lymphocytic Leukemia: ERIC Perspectives and Recommendations

Baliakas, Panagiotis; Espinet, Blanca; Mellink, Clemens; Jarosova, Marie et al.

Ingår i HemaSphere, 2022

• DOI för Cytogenetics in Chronic Lymphocytic Leukemia: ERIC Perspectives and Recommendations
• Ladda ner fulltext (pdf) av Cytogenetics in Chronic Lymphocytic Leukemia: ERIC Perspectives and Recommendations

Clonal haematopoiesis as a risk factor for therapy-related myeloid neoplasms in patients with chronic lymphocytic leukaemia treated with chemo-(immuno)therapy

Voso, Maria-Teresa; Pandzic, Tatjana; Falconi, Giulia; Dencic-Fekete, Marija et al.

Ingår i British Journal of Haematology, s. 103-113, 2022

• DOI för Clonal haematopoiesis as a risk factor for therapy-related myeloid neoplasms in patients with chronic lymphocytic leukaemia treated with chemo-(immuno)therapy

Familial platelet disorder due to germline exonic deletions in RUNX1: a diagnostic challenge with distinct alterations of the transcript isoform equilibrium

Engvall, Marie; Karlsson, Ylva; Kuchinskaya, Ekaterina; Jörnegren, Åsa et al.

Ingår i Leukemia and Lymphoma, s. 2311-2320, 2022

• DOI för Familial platelet disorder due to germline exonic deletions in RUNX1: a diagnostic challenge with distinct alterations of the transcript isoform equilibrium
• Ladda ner fulltext (pdf) av Familial platelet disorder due to germline exonic deletions in RUNX1: a diagnostic challenge with distinct alterations of the transcript isoform equilibrium

Five Percent Variant Allele Frequency Is a Reliable Reporting Threshold for TP53 Variants Detected by Next Generation Sequencing in Chronic Lymphocytic Leukemia in the Clinical Setting

Pandzic, Tatjana; Ladenvall, Claes; Engvall, Marie; Mattsson, Mattias et al.

Ingår i HemaSphere, 2022

• DOI för Five Percent Variant Allele Frequency Is a Reliable Reporting Threshold for TP53 Variants Detected by Next Generation Sequencing in Chronic Lymphocytic Leukemia in the Clinical Setting
• Ladda ner fulltext (pdf) av Five Percent Variant Allele Frequency Is a Reliable Reporting Threshold for TP53 Variants Detected by Next Generation Sequencing in Chronic Lymphocytic Leukemia in the Clinical Setting

International validation of the EORTC QLQ-CLL17 questionnaire for assessment of health-related quality of life for patients with chronic lymphocytic leukaemia

Oerlemans, Simone; Efficace, Fabio; Kieffer, Jacobien M.; Kyriakou, Charalampia et al.

Ingår i British Journal of Haematology, s. 431-441, 2022

• DOI för International validation of the EORTC QLQ-CLL17 questionnaire for assessment of health-related quality of life for patients with chronic lymphocytic leukaemia

Chromosome Y loss and drivers of clonal hematopoiesis in myelodysplastic syndrome

Baliakas, Panagiotis; Forsberg, Lars A.

Ingår i Haematologica, s. 329-331, 2021

• DOI för Chromosome Y loss and drivers of clonal hematopoiesis in myelodysplastic syndrome
• Ladda ner fulltext (pdf) av Chromosome Y loss and drivers of clonal hematopoiesis in myelodysplastic syndrome

COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study

Chatzikonstantinou, Thomas; Kapetanakis, Anargyros; Scarfò, Lydia; Karakatsoulis, Georgios et al.

Ingår i Leukemia, s. 3444-3454, 2021

• DOI för COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study
• Ladda ner fulltext (pdf) av COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study

Prognostic and Predictive Implications of Cytogenetics and Genomics

Ljungström, Viktor; Baliakas, Panagiotis

Ingår i Hematology/Oncology Clinics of North America, s. 703-713, 2021

• DOI för Prognostic and Predictive Implications of Cytogenetics and Genomics
• Ladda ner fulltext (pdf) av Prognostic and Predictive Implications of Cytogenetics and Genomics

Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity: a multicenter study

Leeksma, Alexander C.; Baliakas, Panagiotis; Moysiadis, Theodoros; Puiggros, Anna et al.

Ingår i Haematologica, s. 87-97, 2021

• DOI för Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity: a multicenter study
• Ladda ner fulltext (pdf) av Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity: a multicenter study

Higher-order immunoglobulin repertoire restrictions in CLL: the illustrative case of stereotyped subsets 2 and 169

Gemenetzi, Katerina; Psomopoulos, Fotis; Carriles, Alejandra A.; Gounari, Maria et al.

Ingår i Blood, s. 1895-1904, 2021

• DOI för Higher-order immunoglobulin repertoire restrictions in CLL: the illustrative case of stereotyped subsets 2 and 169

Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL

Agathangelidis, Andreas; Chatzidimitriou, Anastasia; Gemenetzi, Katerina; Giudicelli, Veronique et al.

Ingår i Blood, s. 1365-1376, 2021

• DOI för Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL

Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome

Amini, Rose-Marie; Ljungström, Viktor; Abdulla, Maysaa; Cavelier, Lucia et al.

Ingår i American Journal of Hematology, 2020

• DOI för Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome
• Ladda ner fulltext (pdf) av Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome

Nordic Guidelines for Germline Predisposition to Myeloid Neoplasms in Adults: Recommendations for Genetic Diagnosis, Clinical Management and Follow-up

Baliakas, Panagiotis; Tesi, Bianca; Wartiovaara-Kautto, Ulla; Stray-Pedersen, Asbjörg et al.

Ingår i HemaSphere, 2019

• DOI för Nordic Guidelines for Germline Predisposition to Myeloid Neoplasms in Adults: Recommendations for Genetic Diagnosis, Clinical Management and Follow-up
• Ladda ner fulltext (pdf) av Nordic Guidelines for Germline Predisposition to Myeloid Neoplasms in Adults: Recommendations for Genetic Diagnosis, Clinical Management and Follow-up

ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants

Luo, Xi; Feurstein, Simone; Mohan, Shruthi; Porter, Christopher C. et al.

Ingår i Blood Advances, s. 2962-2979, 2019

• DOI för ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants

Different time-dependent changes of risk for evolution in chronic lymphocytic leukemia with mutated or unmutated antigen B cell receptors

Moysiadis, Theodoros; Baliakas, Panagiotis; Rossi, Davide; Catherwood, Mark et al.

Ingår i Leukemia, s. 1801-1805, 2019

• DOI för Different time-dependent changes of risk for evolution in chronic lymphocytic leukemia with mutated or unmutated antigen B cell receptors

Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact

Baliakas, Panagiotis; Jeromin, Sabine; Iskas, Michalis; Puiggros, Anna et al.

Ingår i Blood, s. 1205-1216, 2019

• DOI för Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact

Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia

Baliakas, Panagiotis; Moysiadis, Theodoros; Hadzidimitriou, Anastasia; Xochelli, Aliki et al.

Ingår i Haematologica, s. 360-369, 2019

• DOI för Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia
• Ladda ner fulltext (pdf) av Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia

Novel variants in Nordic patients referred for genetic testing of telomere-related disorders

Norberg, Anna; Rosen, Anna; Raaschou-Jensen, Klas; Kjeldsen, Lars et al.

Ingår i European Journal of Human Genetics, s. 858-867, 2018

• DOI för Novel variants in Nordic patients referred for genetic testing of telomere-related disorders

No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy

Baliakas, Panagiotis; Mattsson, Mattias; Hadzidimitriou, Anastasia; Minga, Eva et al.

Ingår i Haematologica, 2018

• DOI för No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy

Refractory chronic "ITP": When platelet size matters

Baliakas, Panagiotis; Kättström, Magdalena; Rossing, Maria; Amini, Rose-Marie

Ingår i Clinical Case Reports, s. 1779-1780, 2018

• DOI för Refractory chronic "ITP": When platelet size matters
• Ladda ner fulltext (pdf) av Refractory chronic "ITP": When platelet size matters

Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes

Xochelli, Aliki; Baliakas, Panagiotis; Kavakiotis, Ioannis; Agathangelidis, Andreas et al.

Ingår i Clinical Cancer Research, s. 5292-5301, 2017

• DOI för Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes

CYTOGENETIC COMPLEXITY IN CHRONIC LYMPHOCYTIC LEUKEMIA: DEFINITIONS, ASSOCIATIONS WITH OTHER BIOMARKERS AND CLINICAL IMPACT; A RETROSPECTIVE STUDY ON BEHALF OF ERIC

Baliakas, Panagiotis; Jeromin, S.; Iskas, M.; Puiggros, A. et al.

Ingår i Haematologica, s. 170-170, 2017

Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations with other bio-markers and clinical impact

Baliakas, Panagiotis; Jeronim, Sabine; Iskas, Michalis; Puiggros, Anna et al.

Ingår i Leukemia and Lymphoma, s. 65-66, 2017

• DOI för Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations with other bio-markers and clinical impact

Is FCR the treatment of choice for IGHV mutated CLL without poor FISH cytogenetics?

Baliakas, Panagiotis; Moreno, Carol; Cuellar, Carolina; Scarfo, Lydia et al.

Ingår i Leukemia and Lymphoma, s. 170-171, 2017

• DOI för Is FCR the treatment of choice for IGHV mutated CLL without poor FISH cytogenetics?

Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: updated ERIC recommendations

Rosenquist, Richard; Ghia, P.; Hadzidimitriou, A.; Sutton, Lesley Ann et al.

Ingår i Leukemia, s. 1477-1481, 2017

• DOI för Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: updated ERIC recommendations
• Ladda ner fulltext (pdf) av Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: updated ERIC recommendations

Immunoglobulin genes in chronic lymphocytic leukemia: key to understanding the disease and improving risk stratification

Sutton, Lesley Ann; Hadzidimitriou, Anastasia; Baliakas, Panagiotis; Agathangelidis, Andreas et al.

Ingår i Haematologica, s. 968-971, 2017

• DOI för Immunoglobulin genes in chronic lymphocytic leukemia: key to understanding the disease and improving risk stratification

EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia

Young, Emma; Noerenberg, Daniel; Mansouri, Larry; Ljungström, Viktor et al.

Ingår i Leukemia, s. 1547-1554, 2017

• DOI för EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia

Tp53 gene p72R polymorphism in chronic lymphocytic leukemia: incidence and clinical significance amongst cases with unmutated immunoglobulin receptors

Gemenetzi, Katerina; Galigalidou, Chrysi; Vlachonikola, Elisavet; Stalika, Evangelia et al.

Ingår i Leukemia and Lymphoma, s. 726-728, 2017

• DOI för Tp53 gene p72R polymorphism in chronic lymphocytic leukemia: incidence and clinical significance amongst cases with unmutated immunoglobulin receptors

Prognostic impact of epigenetic classification in chronic lymphocytic leukemia: The case of subset #2

Bhoi, Sujata; Ljungström, Viktor; Baliakas, Panagiotis; Mattsson, Mattias et al.

Ingår i Epigenetics, s. 449-455, 2016

• DOI för Prognostic impact of epigenetic classification in chronic lymphocytic leukemia: The case of subset #2

The histone methyltransferase EZH2 as a novel prosurvival factor in clinically aggressive chronic lymphocytic leukemia

Papakonstantinou, Nikos; Ntoufa, Stavroula; Chartomatsidou, Elisavet; Kotta, Konstantia et al.

Ingår i Oncotarget, s. 35946-35959, 2016

• DOI för The histone methyltransferase EZH2 as a novel prosurvival factor in clinically aggressive chronic lymphocytic leukemia

Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations

Blanco, Gonzalo; Puiggros, Anna; Baliakas, Panagiotis; Athanasiadou, Anastasia et al.

Ingår i Oncotarget, s. 80916-80924, 2016

• DOI för Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations
• Ladda ner fulltext (pdf) av Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations

Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors

Sutton, Lesley-Ann; Young, Emma; Baliakas, Panagiotis; Hadzidimitriou, Anastasia et al.

Ingår i Haematologica, s. 959-967, 2016

• DOI för Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors

UGT2B17 expression: a novel prognostic marker within IGHV-mutated chronic lymphocytic leukemia?

Bhoi, Sujata; Baliakas, Panagiotis; Cortese, Diego; Mattsson, Mattias et al.

Ingår i Haematologica, 2016

• DOI för UGT2B17 expression: a novel prognostic marker within IGHV-mutated chronic lymphocytic leukemia?

No Improvement In Long-Term Overall Survival After The Introduction Of Chemo(Immuno)Therapy For Chronic Lymphocytic Leukemia Patients Belonging To Stereotyped Subset #2

Baliakas, Panagiotis; Mattsson, Mattias; Hadzidimitriou, A.; Minga, E. et al.

Ingår i Haematologica, s. 231-231, 2016

Hypogammaglobulinemia In Chronic Lymphocytic Leukemia: Clinicobiological Associations

Baliakas, Panagiotis; Xochelli, Aliki; Minga, E.; Karavalakis, G. et al.

Ingår i Haematologica, s. 438-438, 2016

Additional trisomies amongst patients with chronic lymphocytic leukemia carrying trisomy 12: the accompanying chromosome makes a difference

Baliakas, Panagiotis; Puiggros, Anna; Xochelli, Aliki; Sutton, Lesley-Ann et al.

Ingår i Haematologica, s. 299-302, 2016

• DOI för Additional trisomies amongst patients with chronic lymphocytic leukemia carrying trisomy 12: the accompanying chromosome makes a difference

An Immunogenetic Signature of Ongoing Antigen Interactions in Splenic Marginal Zone Lymphoma Expressing IGHV1-2*04 Receptors

Bikos, Vasilis; Karypidou, Maria; Stalika, Evangelia; Baliakas, Panagiotis et al.

Ingår i Clinical Cancer Research, s. 2032-2040, 2016

• DOI för An Immunogenetic Signature of Ongoing Antigen Interactions in Splenic Marginal Zone Lymphoma Expressing IGHV1-2*04 Receptors

Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations

Ljungström, Viktor; Cortese, Diego; Young, Emma; Pandzic, Tatjana et al.

Ingår i Blood, s. 1007-1016, 2016

• DOI för Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations

Gains of 8q and losses of 8p is associated with the presence of complex karyotype improving prognosis in patients with lymphatic leukemia chronic and alterations of tp53

Gonzalo, Blanco; Anna, Puiggros; Baliakas, Panagiotis; Anastasia, Athanasiadou et al.

Ingår i Haematologica, s. 196-197, 2016

ATM mutations in major stereotyped subsets of chronic lymphocytic leukemia: enrichment in subset #2 is associated with markedly short telomeres

Navrkalova, Veronika; Young, Emma; Baliakas, Panagiotis; Radova, Lenka et al.

Ingår i Haematologica, 2016

• DOI för ATM mutations in major stereotyped subsets of chronic lymphocytic leukemia: enrichment in subset #2 is associated with markedly short telomeres

Chromosome 8 Abnormalities Are Associated With An Even Worse Outcome And Karyotype Complexity In Patients With Chronic Lymphocytic Leukemia And Tp53 Aberrations

Blanco, G.; Puiggros, A.; Baliakas, Panagiotis; Athanasiadou, A. et al.

Ingår i Haematologica, s. 229-230, 2016

Immunoglobulin heavy variable (IGHV) genes and alleles: new entities, new names and implications for research and prognostication in chronic lymphocytic leukaemia

Xochelli, Aliki; Agathangelidis, Andreas; Kavakiotis, Ioannis; Minga, Evangelia et al.

Ingår i Immunogenetics, s. 61-66, 2015

• DOI för Immunoglobulin heavy variable (IGHV) genes and alleles: new entities, new names and implications for research and prognostication in chronic lymphocytic leukaemia

ATM Mutations in Major Stereotyped CLL Subsets: Enrichment in Subset #2 is Associated with Unfavourable Outcome

Navrkalova, Veronika; Young, Emma; Baliakas, Panagiotis; Radova, Lenka et al.

Ingår i Blood, 2015

Personalized Modeling of Disease Evolution in CLL: Does Statistical Significance Translate into Predictive Accuracy?

Chatzilari, Elisavet; Baliakas, Panagiotis; Xochelli, Aliki; Maronidis, Anastasios et al.

Ingår i Blood, 2015

EGR2 Mutations in Chronic Lymphocytic Leukemia: A New Bad Player

Noerenberg, Daniel; Young, Emma; Ljungström, Viktor; Mansouri, Larry et al.

Ingår i Blood, 2015

CLL with Mutated IGHV4-34 Antigen Receptors Is Clinically Heterogeneous: Antigen Receptor Stereotypy Makes the Difference

Xochelli, Aliki; Baliakas, Panagiotis; Agathangelidis, Andreas; Hadzidimitriou, Anastasia et al.

Ingår i Blood, 2015

EGR2 mutations in chronic lymphocytic leukemiam - a new bad player?

Young, Emma; Norenberg, Daniel; Ljungstrom, Viktor; Mansouri, Larry et al.

Ingår i Leukemia and Lymphoma, s. 83-85, 2015

ARResT/AssignSubsets: a novel application for robust subclassification of chronic lymphocytic leukemia based on B cell receptor IG stereotypy

Bystry, Vojtech; Agathangelidis, Andreas; Bikos, Vasilis; Sutton, Lesley Ann et al.

Ingår i Bioinformatics, s. 3844-3846, 2015

• DOI för ARResT/AssignSubsets: a novel application for robust subclassification of chronic lymphocytic leukemia based on B cell receptor IG stereotypy

HIGHER-ORDER IMMUNOGLOBULIN SEQUENCE RELATIONS FOR MAJOR SUBSETS OF CHRONIC LYMPHOCYTIC LEUKEMIA: UNIQUENESS VERSUS EQUIVALENCE

Agathangelidis, A.; Bystry, V.; Hadzidimitriou, A.; Sutton, L. A. et al.

Ingår i Haematologica, s. 47-48, 2015

REFINING PROGNOSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH SOMATICALLY HYPERMUTATED B-CELL RECEPTORS: A NOVEL PROGNOSTIC INDEX ON BEHALF OF THE EUROPEAN RESEARCH INITIATIVE ON CLL (ERIC)

Baliakas, Panagiotis; Hadzidimitriou, A.; Mattsson, Mattias; Xochelli, Aliki et al.

Ingår i Haematologica, s. 52-52, 2015

ADDITIONAL TRISOMIES AMONGST PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA CARRYING TRISOMY 12: THE PARTNER CHROMOSOME MAKES A DIFFERENCE

Baliakas, Panagiotis; Puiggros, A.; Xochelli, Aliki; Sutton, L. -A et al.

Ingår i Haematologica, s. 224-224, 2015

Personalized Modeling of Disease Evolution in CLL: Does Statistical Significance Translate into Predictive Accuracy?

Chatzilari, Elisavet; Baliakas, Panagiotis; Xochelli, Aliki; Maronidis, Anastasios et al.

Ingår i Blood, 2015

Prognostic relevance of MYD88 mutations in CLL: the jury is still out

Baliakas, Panagiotis; Hadzidimitriou, Anastasia; Agathangelidis, Andreas; Rossi, Davide et al.

Ingår i Blood, s. 1043-1044, 2015

• DOI för Prognostic relevance of MYD88 mutations in CLL: the jury is still out

Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations

Baliakas, Panagiotis; Agathangelidis, Andreas; Hadzidimitriou, Anastasia; Sutton, Lesley-Ann et al.

Ingår i Blood, s. 856-859, 2015

• DOI för Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations

Recurrent mutations refine prognosis in chronic lymphocytic leukemia

Baliakas, Panagiotis; Hadzidimitriou, A; Sutton, Lesley Ann; Rossi, D et al.

Ingår i Leukemia, s. 329-336, 2015

• DOI för Recurrent mutations refine prognosis in chronic lymphocytic leukemia

Superior Long-Term Repopulating Capacity of G-CSF+Plerixafor-Mobilized Blood: Implications for Stem Cell Gene Therapy by Studies in the Hbb(th-3) Mouse Model

Psatha, Nikoleta; Sgouramali, Eleni; Gkountis, Antonios; Siametis, Athanasios et al.

Ingår i Human Gene Therapy Methods, s. 317-327, 2014

• DOI för Superior Long-Term Repopulating Capacity of G-CSF+Plerixafor-Mobilized Blood: Implications for Stem Cell Gene Therapy by Studies in the Hbb(th-3) Mouse Model

Trans location t(2;7)(p11.2;q21.2): a rare genetic aberration associated with B-cell lymphoproliferative disorders of marginal-zone origin

Xochelli, Aliki; Baliakas, Panagiotis; Moore, Sarah; Sole, Francesc et al.

Ingår i Cancer Genetics, s. 281-283, 2014

• DOI för Trans location t(2;7)(p11.2;q21.2): a rare genetic aberration associated with B-cell lymphoproliferative disorders of marginal-zone origin

Not All IGHV3-21 CLL Are Equal: Subset #2 Displays a Distinctive Clinicobiological Profile with Remarkable Similarities to Subset #169, its Close Immunogenetic Relative

Baliakas, Panagiotis; Hadzidimitriou, A.; Sutton, L. A.; Minga, E. et al.

Ingår i Haematologica, s. 48-49, 2014

Immunoglobulin Heavy Variable Genes and Alleles: New Entities, New Names and Implications for Research and Prognostication in CLL

Xochelli, A.; Agathangelidis, A.; Kavakiotis, I.; Minga, E. et al.

Ingår i Haematologica, s. 49-49, 2014

Cytogenetic Evolution Patterns in Chronic Lymphocytic Leukemia

Iskas, M.; Papaioannou, G.; Baliakas, Panagiotis; Gaitatzi, M. et al.

Ingår i Haematologica, s. 314-314, 2014

Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study

Baliakas, Panagiotis; Hadzidimitriou, Anastasia; Sutton, Lesley-Ann; Minga, Eva et al.

Ingår i LANCET HAEMATOLOGY, 2014

• DOI för Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study

Subset-Specific Spectra of Recurrent Gene Mutations in Chronic Lymphocytic Leukemia with Stereotyped B-Cell Receptors

Sutton, Lesley-Ann; Young, Emma; Baliakas, Panagiotis; Hadzidimitriou, Anastasia et al.

Ingår i Blood, 2014

The frequency of TP53 gene defects differs between chronic lymphocytic leukaemia subgroups harbouring distinct antigen receptors

Malcikova, Jitka; Stalika, Evangelia; Davis, Zadie; Plevova, Karla et al.

Ingår i British Journal of Haematology, s. 621-625, 2014

• DOI för The frequency of TP53 gene defects differs between chronic lymphocytic leukaemia subgroups harbouring distinct antigen receptors

Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: A systematic reappraisal of classic cytogenetic data

Baliakas, Panagiotis; Iskas, Michalis; Gardiner, Anne; Davis, Zadie et al.

Ingår i American Journal of Hematology, s. 249-255, 2014

• DOI för Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: A systematic reappraisal of classic cytogenetic data

Clonal B-cell lymphocytosis exhibiting immunophenotypic features consistent with a marginal-zone origin: is this a distinct entity?

Xochelli, Aliki; Kalpadakis, Christina; Gardiner, Anne; Baliakas, Panagiotis et al.

Ingår i Blood, s. 1199-1206, 2014

• DOI för Clonal B-cell lymphocytosis exhibiting immunophenotypic features consistent with a marginal-zone origin: is this a distinct entity?

Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2

Strefford, J. C.; Sutton, Lesley Ann; Baliakas, Panagiotis; Agathangelidis, A. et al.

Ingår i Leukemia, s. 2196-2199, 2013

• DOI för Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2

Clonal evolution patterns in high-risk chronic lymphocytic leukemia treated with ibrutinib

Mattsson, Mattias; Ljungström, Viktor; Djureinovic, Tatjana; Mansouri, Larry et al.

ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-2024 update

Malcikova, Jitka; Pavlova, Sarka; Baliakas, Panagiotis; Chatzikonstantinou, Thomas et al.

Ingår i Leukemia, s. 1455-1468, 2024

• DOI för ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-2024 update
• Ladda ner fulltext (pdf) av ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-2024 update

Landscape of TP53 Alterations in Chronic Lymphocytic Leukemia via Data Mining Mutation Databases

Soussi, Thierry; Baliakas, Panagiotis

Ingår i Frontiers in Oncology, 2022

• DOI för Landscape of TP53 Alterations in Chronic Lymphocytic Leukemia via Data Mining Mutation Databases
• Ladda ner fulltext (pdf) av Landscape of TP53 Alterations in Chronic Lymphocytic Leukemia via Data Mining Mutation Databases

Biology and Treatment of High-Risk CLL: Significance of Complex Karyotype

Chatzikonstantinou, Thomas; Demosthenous, Christos; Baliakas, Panagiotis

Ingår i Frontiers in Oncology, 2021

• DOI för Biology and Treatment of High-Risk CLL: Significance of Complex Karyotype
• Ladda ner fulltext (pdf) av Biology and Treatment of High-Risk CLL: Significance of Complex Karyotype

Prognostic indices in chronic lymphocytic leukaemia: where do we stand how do we proceed?

Baliakas, Panagiotis; Mattsson, Mattias; Stamatopoulos, Kostas; Rosenquist Brandell, Richard

Ingår i Journal of Internal Medicine, s. 347-357, 2016

• DOI för Prognostic indices in chronic lymphocytic leukaemia: where do we stand how do we proceed?

Splenic marginal-zone lymphoma: ontogeny and genetics

Baliakas, Panagiotis; Strefford, Jonathan C.; Bikos, Vasilis; Parry, Marina et al.

Ingår i Leukemia and Lymphoma, s. 301-310, 2015

• DOI för Splenic marginal-zone lymphoma: ontogeny and genetics

Stereotyped B-cell receptors in chronic lymphocytic leukemia

Agathangelidis, Andreas; Vardi, Anna; Baliakas, Panagiotis; Stamatopoulos, Kostas

Ingår i Leukemia and Lymphoma, s. 2252-2261, 2014

• DOI för Stereotyped B-cell receptors in chronic lymphocytic leukemia

Reappraising prognosis in chronic lymphocytic leukemia

Baliakas, Panagiotis

2016

• Ladda ner fulltext (pdf) av Reappraising prognosis in chronic lymphocytic leukemia